TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia.
TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia.
复制标题
TREM2调节人iPSC衍生的小胶质细胞中嘌呤能受体介导的钙信号传导和运动性
DOI:
10.7554/elife.73021
复制
发表时间:
2022-02-22
期刊:
影响因子:
7.7
通讯作者:
Cahalan MD
中科院分区:
文献类型:
--
作者:
Jairaman A;McQuade A;Granzotto A;Kang YJ;Chadarevian JP;Gandhi S;Parker I;Smith I;Cho H;Sensi SL;Othy S;Blurton-Jones M;Cahalan MD
The membrane protein TREM2 (Triggering Receptor Expressed on Myeloid cells 2) regulates key microglial functions including phagocytosis and chemotaxis. Loss-of-function variants of TREM2 are associated with increased risk of Alzheimer’s disease (AD). Because abnormalities in Ca2+ signaling have been observed in several AD models, we investigated TREM2 regulation of Ca2+ signaling in human induced pluripotent stem cell-derived microglia (iPSC-microglia) with genetic deletion of TREM2. We found that iPSC-microglia lacking TREM2 (TREM2 KO) show exaggerated Ca2+ signals in response to purinergic agonists, such as ADP, that shape microglial injury responses. This ADP hypersensitivity, driven by increased expression of P2Y12 and P2Y13 receptors, results in greater release of Ca2+ from the endoplasmic reticulum stores, which triggers sustained Ca2+ influx through Orai channels and alters cell motility in TREM2 KO microglia. Using iPSC-microglia expressing the genetically encoded Ca2+ probe, Salsa6f, we found that cytosolic Ca2+ tunes motility to a greater extent in TREM2 KO microglia. Despite showing greater overall displacement, TREM2 KO microglia exhibit reduced directional chemotaxis along ADP gradients. Accordingly, the chemotactic defect in TREM2 KO microglia was rescued by reducing cytosolic Ca2+ using a P2Y12 receptor antagonist. Our results show that loss of TREM2 confers a defect in microglial Ca2+ response to purinergic signals, suggesting a window of Ca2+ signaling for optimal microglial motility.